A Prospective single centre post market clinical followup study to investigate the clinical outcomes of a hydrophobic trifocal IO

ethradhama super speciality eye hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1Bilateral Implantation
•2Age of patient >21 Years
•3Cataractous eyes with no comorbidity.
•4Regular corneal topography and corneal astigmatism
•5Preoperative & postoperative corneal astigmatism of <= 0.75D
•6Spontaneously emitting the desire for spectacle independence after surgery and with realistic expectation.
•7Availability, willingness and sufficient cognitive awareness to comply with examination procedures
•8Signed informed consent.

•1Age of patient <21 years
•2Active ocular disease in the operative eye, for example, chronic uveitis, proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication, corneal decompensation and corneal endothelial cell insufficiency
•3Subjects with any systemic disease that could increase operative risk or confound the outcome
•4Pregnant or lactating or planning a pregnancy at the time of enrolment
•5Any patient who is taking part in another study involving ocular surgery
•6Significant irregular corneal astigmatism.
•7Any ocular comorbidity
•8Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under Mesopic/scotopic conditions) Patients receiving chloroquine treatment.

发起方

ethradhama super speciality eye hospital